Dermatological Drugs: World Market Prospects 2012-2022
http://www.reportlinker.com/p0788690/Dermatological-Drugs-World-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
Report Details
Where are dermatological treatments heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions.
This study assesses drugs to treat human skin disorders. You discover sales predictions at world market, therapeutic submarket, product and national levels to 2022.
How will 24 leading drugs - Valtrex, Zovirax, Protopic, Enbrel and others - perform from 2012? Our report gives you business research and analysis with many sales forecasts.
Also, you see forecasting of five derma submarkets to 2022, finding potential revenues:
• Dermatitis
• Psoriasis
• Acne
• Infectious skin diseases
• Miscellaneous dermatologics.
What does the future hold? The pharma industry has potential for improved treatments and increased revenues from dermatological agents. The R&D pipeline is strong.
Our report discusses GSK, Galderma, Amgen, Abbott, J&J and other pharmaceutical companies, assessing prospects of the industry and market.
Many commercial opportunities in treating skin disorders remain, including increased revenues. You can investigate the future of that area now.
Visiongain's study provides data, analysis and opinion aiming to benefit your research, calculations, meetings and presentations. You find answers in our work.
Revenue forecasts, market shares, developmental trends and discussions
In our report you find revenue forecasting, growth rates and market shares. Also, you have qualitative analyses (including SWOT) and discussion of R&D activities. You receive 121 tables and charts and a research interview.
Advantages of Dermatological Drugs: World Market Prospects 2012-2022 for your work
In particular, this study gives you the following knowledge on the topic:
• Find potential revenues to 2022 for the world market and submarkets
• Discover revenue forecasts to 2022 for 24 leading products
• See market forecasting to 2022 for the US, Japan, the EU5, China and India
• Assess leading companies, discovering activities and outlooks
• Review R&D, seeing pipeline trends
• Investigate competition and opportunities influencing sales
• Find out what will stimulate and restrain the industry and market
• View opinion from the sector, receiving primary research.
There, you find a distinctive mix of quantitative and qualitative analyses with independent predictions. Without our report, you could miss out on information that your competitors are using.
We investigate commercial applications of dermatology, helping you to stay ahead.
Gain business research and analysis for the treatment of skin disorders
Our study is for everybody needing industry and market analyses for dermatological drugs. Find data, trends and answers. Avoid missing out - please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Table of Contents
1. Executive Summary
1.1 World Dermatological Drug Market: Overview of Findings
1.2 Aims, Scope and Format of the Report
1.3 Research and Analysis Methods
2. Introduction to Dermatological Disorders and Their Treatments
2.1 An Introduction to Dermatology
2.1.1 The Structure of the Skin
2.1.2 Hair
2.1.3 Nails
2.1.4 Sweat and Sebaceous Glands
2.2 Functions of the Skin
2.2.1 Protection
2.2.2 Sensation
2.2.3 Vitamin D Synthesis
2.2.4 Temperature Regulation and Heat Insulation
2.2.5 Storage
2.2.6 Prevention of Water Loss
2.3 Common Skin Diseases
2.4 An Introduction to Acne Vulgaris
2.4.1 Acne Conglobata
2.4.2 Acne Fulminans
2.4.3 Gram-Negative Folliculitis
2.4.4 Pyoderma Faciale
2.4.5 Causes of Acne
2.5 An Introduction to Dermatitis
2.5.1 Atopic Dermatitis
2.5.2 Contact Dermatitis
2.5.3 Seborrheic Dermatitis
2.5.4 Nummular Dermatitis
2.5.5 Perioral Dermatitis
2.6 An Introduction to Psoriasis
2.6.1 Plaque Psoriasis
2.6.2 Guttate Psoriasis
2.6.3 Pustular Psoriasis
2.6.4 Inverse Psoriasis
2.6.5 Erythrodermic Psoriasis
2.7 An Introduction to Rosacea
2.7.1 Erythematotelangiectatic Rosacea
2.7.2 Papulopustular Rosacea
2.7.3 Phymatous Rosacea
2.7.4 Ocular Rosacea
2.8 An Introduction to Alopecia
2.8.1 Alopecia Areata
2.8.2 Alopecia Totalis
2.8.3 Alopecia Universalis
2.8.4 Androgenetic Alopecia
2.8.5 Alopecia Barbae
2.8.6 Alopecia Mucinosa
2.8.7 Traction Alopecia
2.8.8 Anagen Effluvium
2.8.9 Telogen Effluvium
2.9 An Introduction to Infectious Diseases of the Skin
2.9.1 Bacterial Skin Infections
2.9.1.1 Impetigo
2.9.1.2 Folliculitis
2.9.1.3 Cellulitis
2.9.1.4 Furunculosis
2.9.1.5 Carbuncle
2.9.2 Fungal Skin Infections
2.9.2.1 Tinea Pedis (Athlete's Foot)
2.9.2.2 Tinea Unguium (Ringworm of the Nails)
2.9.2.3 Tinea Corporis (Ringworm of the Skin)
2.9.2.4 Tinea Capitis (Scalp Ringworm)
2.9.2.5 Kerions
2.9.3 Viral Skin Infections
2.9.3.1 Molluscum Contagiosum
2.9.3.2 Warts
2.9.3.3 Herpes Simplex
2.9.3.4 Chickenpox
2.9.3.5 Herpes Zoster
2.10 Common Skin Treatments
2.10.1 Creams and Semisolid Emulsions
2.10.2 Ointments
2.10.3 Lotions
2.10.4 Solutions
2.10.5 Occlusive Therapy
2.10.6 Cleansing Agents
2.10.7 Protecting Powders and Hydrophilic Polymer
2.10.8 Anti-Infective Agents
2.10.9 Anti-Inflammatory Agents
3. The World Dermatological Drug Market, 2012-2022
3.1 The World Dermatological Drug Market in 2010
3.2 The Infectious Skin Diseases Market Dominates the World Dermatological Drug Market
3.3 Biologic Agents for the Treatment of Psoriasis Are the Leading Drugs in the Dermatologics Market
3.4 The Changing Landscape of the Dermatological Drug Market
3.5 The World Dermatological Drug Market: Forecasts, 2012-2022
3.5.1 Market Shares of Leading Segments
3.5.1.1 The Psoriasis Market Will Achieve the Greatest Increase in Market Share
3.6 The Future of the Dermatological Drug Market
3.6.1 Blockbuster Sales - Hard to Achieve?
4. The Infectious Skin Diseases Drug Market, 2012-2022
4.1 The Infectious Skin Diseases Drug Market in 2010
4.1.1 Antiviral Products Led the Dermatological Anti-Infectives Market in 2010
4.1.2 Systemic Antiviral Products Lead the Infectious Skin Diseases Drug Market
4.2 World Infectious Skin Diseases Drug Market Forecast, 2012-2022
4.3 Valtrex (Valacyclovir)
4.3.1 Patent Expiry and the End of Blockbuster Revenues
4.3.2 Valtrex Sales Will Continue to Decline
4.4 Zovirax
4.4.1 Zovirax Sales Forecast, 2012-2022
4.5 Aldara/Zyclara (Imiquimod)
4.5.1 Patent Expiry and Other Challenges
4.5.2 Lifecycle Management
4.5.3 Aldara Sales Forecast, 2012-2022
4.6 Bactroban (Mupirocin)
4.6.1 Bactroban Sales Forecast, 2012-2022
4.7 Lamisil (Terbinafine)
4.7.1 Lamisil Sales Forecast, 2012-2022
4.8 The Infectious Skin Diseases Market - Summary
5. The Dermatitis Drug Market, 2012-2022
5.1 The Dermatitis Drug Market in 2010
5.1.1 Corticosteroids are the Leading Dermatitis Treatment
5.2 Dermatitis Drug Market Forecast, 2012-2022
5.3 Protopic (Tacrolimus)
5.3.1 Protopic Sales Forecast, 2012-2022
5.3.2 Protopic Benefits from Expanded Indication
5.3.3 Will Protopic's Strong Sales Increase Recur?
5.4 Elidel (Pimecrolimus)
5.4.1 Elidel Rights Sold
5.4.2 Regulatory Matters
5.4.3 Elidel Sales Forecast, 2012-2022
Be the first to review this article
